首页> 外文期刊>Daru Journal of pharmaceutical sciences. >Doxorubicin-conjugated PLA-PEG-Folate based polymeric micelle for tumor-targeted delivery: Synthesis and in vitro evaluation
【24h】

Doxorubicin-conjugated PLA-PEG-Folate based polymeric micelle for tumor-targeted delivery: Synthesis and in vitro evaluation

机译:用于肿瘤靶向递送的基于阿霉素结合的PLA-PEG-叶酸酯的聚合物胶束:合成和体外评估

获取原文
获取外文期刊封面目录资料

摘要

BackgroundSelective delivery of anticancer agents to target areas in the body is desirable to minimize the side effects while maximizing the therapeutic efficacy. Anthracycline antibiotics such as doxorubicin (DOX) are widely used for treatment of a wide variety of solid tumors.This study evaluated the potential of a polymeric micellar formulation of doxorubicin as a nanocarrier system for targeted therapy of a folate-receptor positive human ovarian cancer cell in line.ResultsDOX-conjugated targeting and non-targeting micelles prepared by the dialysis method were about 188 and 182?nm in diameter, respectively and their critical micelle concentration was 9.55?μg/ml. The DOX-conjugated micelles exhibited a potent cytotoxicity against SKOV3 human ovarian cancer cells. Moreover, the targeting micelles showed higher cytotoxicity than that of non-targeting ones (IC50?=?4.65?μg/ml vs 13.51?μg/ml).ConclusionThe prepared micelle is expected to increase the efficacy of DOX against cancer cells and reduce its side effects.
机译:背景技术期望将抗癌剂选择性地递送至体内的靶区域以使副作用最小化,同时使治疗功效最大化。蒽环类抗生素如阿霉素(DOX)被广泛用于治疗多种实体瘤。本研究评估了多柔比星聚合物胶束制剂作为纳米载体系统对叶酸受体阳性人类卵巢癌细胞的靶向治疗的潜力结果通过透析方法制备的DOX缀合的靶向和非靶向胶束的直径分别约为188和182?nm,临界胶束浓度为9.55?μg/ ml。与DOX结合的胶束对SKOV3人卵巢癌细胞显示出有效的细胞毒性。此外,靶向胶束的细胞毒性要高于非靶向胶束(IC50?=?4.65?g / ml vs 13.51?μg/ ml)。结论制备的胶束有望提高DOX对癌细胞的疗效并降低其毒性。副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号